FDA STATE_REFERRAL_LETTER - Barclay, Luke, & Pillai Specialty Pharmacy, PLLC - November 28, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This STATE REFERRAL LETTER record concerns Barclay, Luke, & Pillai Specialty Pharmacy, PLLC, with an inspection on November 28, 2022, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
Inspection Date: November 28, 2022
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Rumany C. Penn (Compliance Officer)
Sean M. Barclay
Steven E. Porter (Program Division Director)
Dave Wuest

Open in Dashboard

ID · 82530ed6-9f46-4c08-bcbb-725fd6eee63b

Violation Codes3

FD&C Act 503A21 CFR 20.64(d)(3)21 CFR 20.88

Full citation text and observation details available on the Dashboard.